AUS
NZ
UK
CA
USA
IND
Health
Why DroneShield (ASX:DRO) Is Leading the Defence Conversation Alongside IPX and SIG
June 20, 2026 09:50 AM AEST| By SamDroneShield, IperionX and Sigma Healthcare continue attracting attention through exposure to defence technology, critical minerals and healthcare infrastructure themes.
CSL (ASX:CSL) Leads Healthcare Comeback, But Is the Rally Real?
June 19, 2026 04:57 PM AEST| By SamAustralia's healthcare sector rebounded sharply as capital shifted from resources into growth stocks, lifting CSL, Cochlear, ResMed, Pro Medicus and Telix and renewing attention on the sector's longer-term outlook.
Cochlear (ASX:COH): The Shock That Sent a Healthcare Giant Tumbling
June 19, 2026 04:55 PM AEST| By SamCochlear’s earnings downgrade triggered a sharp market reassessment as weaker referrals, hospital constraints and cost-of-living pressures disrupted growth expectations for the hearing-implant leader.
Is Aventine Resources Worth Watching as Its $20M Raise Nears Its Close?
June 20, 2026 01:11 AM AEST| By Sonal Goyal
Could Lumos Diagnostics Be Approaching a Turning Point?
June 19, 2026 11:47 AM AEST| By SamLumos Diagnostics is gaining attention as analysts assess its path towards profitability, supported by healthcare sector demand and a debt-free balance sheet.
Cynata’s Double Setback: What Happens to the Cymerus Platform Now?
June 19, 2026 11:37 AM AEST| By SamCynata’s latest clinical setback has intensified focus on the future of the Cymerus platform, with management now reviewing strategic options following recent trial disappointments.
After a Brutal Slide, Could CSL Be Preparing a Comeback?
June 19, 2026 09:56 AM AEST| By SamCSL remains a major focus within Australia's healthcare sector as analysts evaluate valuation, innovation capabilities, and the company's position as a global biotechnology leader.
Aura Consolidated Group: Should This US Digital Safety Company Be on Your ASX Watchlist?
June 20, 2026 01:00 AM AEST| By Sonal Goyal
Telix Expands Global Cancer Strategy Through Landmark Partnerships
June 18, 2026 09:30 PM AEST| By SamTelix is accelerating its global radiopharmaceutical ambitions through major healthcare collaborations, theranostics research initiatives and expanded funding, reinforcing its growing presence in advanced cancer imaging and targeted treatment develop...
Healthcare's Surprise Comeback: Is This the Turn Investors Missed?
June 18, 2026 09:21 PM AEST| By SamAustralia's healthcare sector has staged a notable recovery, led by CSL and supported by Cochlear, ResMed, Pro Medicus and Telix Pharmaceuticals as the market reassesses valuations and long-term sector strengths.
Can ASX All Ordinaries Healthcare Stocks Find Cleaner Growth?
June 18, 2026 02:35 PM AEST| By SamHealthcare stocks are entering a more selective phase as markets focus on imaging contracts, diagnostics demand, biotechnology execution and commercial quality to identify cleaner growth opportunities.
What Is Driving Investor Interest in IDP Education (ASX:IEL) Stock?
June 19, 2026 01:01 PM AEST| By Sonal GoyalShares of IDP Education Limited (ASX:IEL) rose 6.67% to AUD 2.560 in the latest trading session, increasing AUD 0.160 from the previous close of AUD 2.400. The stock traded within a daily range of AUD 2.515 to AUD 2.830, reflecting increased market activity throughout …
AI Tailwinds Put ASX Healthcare Devices Back In Focus
June 18, 2026 02:32 PM AEST| By SamHealthcare stocks are facing a demand reset as device makers, diagnostics groups, imaging software providers and biotechnology names are judged on execution, margins and evidence.
Healthcare Recovery Radar: What Is Driving Fresh Interest In ASX Healthcare Stocks?
June 18, 2026 02:30 PM AEST| By SamASX healthcare stocks are regaining attention as investors reassess valuations, quality business models and sector fundamentals amid a more stable market backdrop focused on operational execution.
Why This Emerging Life Sciences Company Just Expanded Its Share Base
June 18, 2026 10:05 AM AEST| By SamVitrafy Life Sciences has applied to quote additional ordinary shares on the ASX, expanding its share capital while supporting liquidity and maintaining flexibility for future corporate initiatives.
Why Did Ora Banda (ASX:OBM) Shares Fall Nearly 6% Today?
June 19, 2026 01:01 PM AEST| By Sonal GoyalShares of Ora Banda Mining Ltd (ASX:OBM) fell 5.81% to AUD 1.215 in the latest trading session, declining AUD 0.074 from the previous close of AUD 1.290. The stock traded within a daily range of AUD 1.200 to AUD 1.290, reflecting heightened market activity …
Defensive Growth Rotation Is Putting Healthcare Back in the Spotlight
June 17, 2026 09:51 PM AEST| By SamHealthcare stocks are returning to focus as defensive growth themes gain momentum, with market participants closely watching earnings quality, cash flow resilience and execution across leading Australian healthcare companies.
Can Medtech Contract Momentum Reshape The Next Move In ASX healthcare?
June 17, 2026 09:49 PM AEST| By SamHealthcare stocks are back on the radar as investors focus on medtech contract quality, earnings visibility and business execution. Companies with strong cash flow, durable revenue and disciplined growth strategies are attracting increased market att...
Healthcare Stocks Catch Breath as CSL Sparks Rebound
June 17, 2026 02:03 PM AEST| By SamASX healthcare stocks have rebounded sharply, led by CSL, as sector rotation and valuation resets bring defensive names back into focus within the ASX 200 environment.
What Triggered Heavy Trading Activity in BHP (ASX:BHP) Stock?
June 19, 2026 01:01 PM AEST| By Sonal GoyalShares of BHP Group Limited (ASX:BHP) fell 5.60% to AUD 61.400 in the latest trading session, declining AUD 3.640 from the previous close of AUD 65.040. The stock traded within a daily range of AUD 61.400 to AUD 63.250, with the share price finishing …
Cochlear (ASX:COH) Guidance Cut Shakes ASX Healthcare
June 17, 2026 02:03 PM AEST| By SamCochlear’s earnings downgrade in 2026 reset expectations across ASX healthcare stocks, highlighting valuation sensitivity and shifting sentiment in premium medical device companies.
ASX Healthcare Winners Stand Out: PME vs RMD
June 17, 2026 02:03 PM AEST| By SamPro Medicus and ResMed highlight how execution, contracts and margin strength define leadership in ASX healthcare, standing out amid mixed sector performance across 2026.
ASX 200 Healthcare Watch: CSL (ASX:CSL) Valuation Debate Deepens
June 17, 2026 04:25 AM AEST| By SamCSL is under renewed focus ahead of earnings as valuation discussions intensify. The biotechnology leader continues to anchor Australia’s healthcare sector through plasma, vaccines and specialty medicines.
Why Are Investors Watching ARB Corporation (ASX:ARB) Shares Closely?
June 19, 2026 01:01 PM AEST| By Sonal GoyalShares of ARB Corporation Limited (ASX:ARB) climbed 3.48% to AUD 19.610 in the latest trading session, increasing AUD 0.660 from the previous close of AUD 18.950. The stock traded within a daily range of AUD 18.950 to AUD 19.610 and finished at the highest …
Watch ResMed’s GLP-1 Fear Fade as Data Tells a Different Story
June 16, 2026 06:12 PM AEST| By SamResMed has been pressured by GLP-1 fears, but real-world data shows combined therapy use is common. This challenges disruption concerns and reshapes sentiment across ASX healthcare stocks in 2026.
Is Healthcare Turning? CSL Leads ASX Sector Bounce
June 16, 2026 06:12 PM AEST| By SamASX healthcare equities see renewed attention as CSL leads sentiment shift, while Cochlear, ResMed and Sigma Healthcare reflect a more segmented sector recovery phase.
Advertise your brand on Kalkine Media